Megaloblastic anemia is one such deficiency, a macrocytic anemia that causes bone marrow to create very large red blood cells
[DOI] [PubMed] [Google Scholar] 107.Kuhajda FP, Landree LE, Ronnett GV
The meaningful benefits shown by Jardiance in the Phase III EMPA-KIDNEY trial are welcome news for adults living with CKD in [the U.S.], Katherine Tuttle, executive director for research at Providence Inland Northwest Health, regional principal investigator for the Institute of Translational Health Sciences, professor of medicine at the University of Washington, and a steering committee member for the trial, said in a prepared statement
For those hospitals, we proposed to compare the hospital's proposed CY 2026 wage index to the hospital's CY 2024 wage index
Vials should be stored in their original packaging or in opaque/dark storage
Short non-diabetic data support remaining at 2.5 mg when weight and insulin-resistance markers are already moving and tolerability favors a hold. The label still positions 2.5 mg as the starter before 5 mg, so it is a defensible low-dose floor for selected users rather than a replacement for the 5 mg obesity-trial floor
